SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2010 | $90,000 | Replaced |
| 3rd Quarter - Report | Jan 20, 2011 | $80,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to biosimilar approval pathway, orphan drugs, end stage renal disease bundling and non-injectable oral equivalents
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Medicare/Medicaid MMM
End Stage Renal Disease (ESRD) bundling and non-injectable oral equivalents;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.